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Abstract 
Objective 
The purpose of this paper was to review the composition, properties, biocompatibility, and the clinical 
results involving the use of mineral trioxide aggregate (MTA) materials in endodontic treatment. 
Methods 
Electronic search of scientific papers from January 1990 to August 2006 was accomplished using 
PubMed and Scopus search engines (search terms: MTA, GMTA, WMTA, mineral AND trioxide AND 
aggregate). 
Results 
Selected exclusion criteria resulted in 156 citations from the scientific, peer-reviewed dental literature. 
MTA materials are derived from a Portland cement parent compound and have been demonstrated to 
be biocompatible endodontic repair materials, with its biocompatible nature strongly suggested by its 
ability to form hydroxyappatite when exposed to physiologic solutions. With some exceptions, MTA 
materials provide better microleakage protection than traditional endodontic repair materials using dye, 
fluid filtration, and bacterial penetration leakage models. In both animal and human studies, MTA 
materials have been shown to have excellent potential as pulp-capping and pulpotomy medicaments 
but studies with long-term follow-up are limited. Preliminary studies suggested a favorable MTA 
material use as apical and furcation restorative materials as well as medicaments for apexogenesis and 
apexification treatments; however, long-term clinical studies are needed in these areas. 
Conclusion 
MTA materials have been shown to have a biocompatible nature and have excellent potential in 
endodontic use. MTA materials are a refined Portland cement material and the substitution of Portland 
cement for MTA products is presently discouraged. Existing human studies involving MTA materials are 
very promising, however, insufficient randomized, double-blind clinical studies of sufficient duration 
exist involving MTA for all of its clinical indications. Further clinical studies are needed in these areas. 
Keywords 
Hydroxyapatite; Portland cement; Biocompatibility; Pulp-capping; Apexification; Root-end filling; 
Pulpotomy; Endodontics; GMTA; WMTA; MTA; Mineral trioxide aggregate 
1. Introduction 
It is estimated that over 24 million endodontic procedures are performed on an annual basis, with up to 
5.5% of those procedures involving endodontic apical surgery, perforation repair, and apexification 
treatment.1 Endodontic surgery is performed to resolve inflammatory processes that cannot be 
successfully treated by conventional techniques, which may be due to complex canal and/or apical 
anatomy and external inflammatory processes.2 Surgical procedures may also be indicated for the 
resolution of procedural misadventures, to include root perforation that may occur either during canal 
instrumentation or post-space preparation.2,3 Surgical treatment usually involves the placement of a 
material designed to seal the root canal contents from the peri-radicular tissues and repair root defects.2 
Understandably, this material should demonstrate the ability to form a seal with dental tissues while 
also exhibiting biocompatible behavior with the periodontal tissues.3 
An ideal endodontic repair material ideally would adhere to tooth structure, maintain a sufficient seal, 
be insoluble in tissue fluids, dimensionally stable, non-resorbable, radiopaque, and exhibit 
biocompatibility if not bioactivity.2,4,5 A number of materials have historically been used for retrograde 
fillings and perforation repair, such as amalgam, zinc-oxide-eugenol cements, composite resin, and 
glass-ionomer cements.4,6 Unfortunately, none of these materials have been able to satisfy the total 
requirements of an ideal material.4,5 
Mineral trioxide aggregate (MTA) is a biomaterial that has been investigated for endodontic applications 
since the early 1990s. MTA was first described in the dental scientific literature in 19937 and was given 
approval for endodontic use by the U.S. Food and Drug Administration in 1998.8 As it will soon follow, 
MTA materials are derived from a Portland cement parent compound: it is interesting that no 
information has been published regarding to any investigations that led to the precise delineation of the 
present MTA materials. The aim of this article is to present a systematic review of the physical 
properties, biocompatibility testing, and pertinent clinical studies involving MTA materials. 
A structured literature review was performed for articles published between January 1990 and August 
2006. The Internet database PubMed (www.ncbi.nlm.nih.gov/entrez) and Scopus (www.scopus.com) 
was used to search for the keywords MTA, GMTA, WMTA, and mineral AND trioxide AND aggregate. For 
further refinement, the following exclusion criteria were defined: Publications were limited to those of 
English language and from the scientific, peer-reviewed literature. Furthermore, publications possessing 
a questionable peer-review process (e.g., manufacturer-supported) were excluded for consideration. 
Although clinical case reports were included, only clinical studies involving appropriate number, 
sufficient controls and analysis were given serious consideration.9 Using the search keywords limited to 
dental publications produced a total of 245 results, of which application of inclusion criteria produced 
the 156 citations that forms the basis for this review (Fig. 1). 
 
Fig. 1. Literature search criteria. 
2. Chemical, physical, and mechanical properties 
MTA materials are a mixture of a refined Portland cement and bismuth oxide, and are reported to 
contain trace amounts of SiO2, CaO, MgO, K2SO4, and Na2SO4.10,11,12 The major component, Portland 
cement, is a mixture of dicalcium silicate, tricalcium silicate, tricalcium aluminate, gypsum, and 
tetracalcium aluminoferrite.10,11,12 Gypsum is an important determinant of setting time, as is 
tetracalcium aluminoferrate, although to a lesser extent.12 MTA products may contain approximately 
half the gypsum content of Portland cement, as well as smaller amounts of aluminum species, which 
provides a longer working time than Portland cement. Although it may be inferred that Portland cement 
could serve as a MTA substitute, it is important to emphasize Portland cement and MTA are not 
identical materials. MTA products have been reported to have a smaller mean particle size, contain 
fewer toxic heavy metals, has a longer working time, and appears to have undergone additional 
processing/purification than regular Portland cements.13,14 
The first MTA material was described as a fine hydrophilic powder composed predominantly of calcium 
and phosphorus ions, with added bismuth oxide to provide radiopacity greater than dentin.15 However, 
later investigations.10,11,16 found phosphorus levels in MTA products to be very low, near electron probe 
microanalysis detection limit, which correlates with the manufacturer's material safety data sheet.17 
Since it is unlikely that a significant compositional change in MTA materials occurred from the time of 
the first report and given that Portland cement is primarily composed of silicate and aluminate 
materials10,13,18,19 earlier reports15 of MTA product phosphorus content are most likely in error.16 
The MTA product powder is mixed with supplied sterile water in a 3:1 powder/liquid ratio and it is 
recommended that a moist cotton pellet be temporarily placed in direct contact with the material and 
left until a follow-up appointment. Upon hydration, MTA materials form a colloidal gel that solidifies to a 
hard structure in approximately 3–4 h,12,15 with moisture from the surrounding tissues purportedly 
assisting the setting reaction.7 Hydrated MTA products have an initial pH of 10.2, which rises to 12.5 
three hours after mixing.11,15 The setting process is described as a hydration reaction of tricalcium 
silicate (3CaO·SiO2) and dicalcium silicate (2CaO·SiO2), which the latter is said to be responsible for the 
development of material strength.12 Although weaker than other materials used for similar purposes, 
MTA compressive strength has been reported to increase in the presence of moisture for up to 21 
days,15 while MTA product microhardness and hydration behavior has been reported to be adversely 
affected with exposure to the pH range of inflammatory environments (pH 5) as compared to 
physiologic conditions (pH 7).3 
MTA materials have been reported to solidify similar to other mineral cements, in which the anhydrous 
material dissolves, followed by the crystallization of hydrates in an interlocking mass.3 The basic 
framework of the hydrated mass is formed by the interlocking of cubic and needle-like crystals in which 
the needle-like crystals form in sharply delineated thick bundles that fill the inter-grain space between 
the cubic crystals.3 The effect of mixing MTA powder with different liquids and additives has shown that 
the choice of preparation liquid can have an effect on setting time and compressive strength.20 Three 
and five percent calcium chloride solutions, a water-based lubricant, and sodium hypochlorite gels 
decreased setting time; however final compressive strength was significantly lower than that obtained 
prepared with sterile water. Preparation with saline and 2% lidocaine anesthetic solution increased 
setting time; but compressive strength was not significantly affected. Interestingly, a MTA product 
prepared with chlorhexidine gluconate gel did not set.20 It seems to reason that the setting reaction of 
MTA products, like its Portland cement parent compound, is a hydration reaction; sufficient water in 
potential preparation liquids must be present for reaction.21 Furthermore, it should also be intuitive that 
the chosen preparation liquid must also possess water with the necessary diffusion ability to be 
available for the hydration reaction. Clinicians may consider different solutions instead of sterile water 
in the preparation of MTA materials; however, clinicians should consider the potential therapeutic gain 
versus the loss of MTA material physical properties in these situations. 
Up to 2002, only one MTA material consisting of gray-colored powder was available, and in that year 
white mineral trioxide aggregate (WMTA) was introduced as ProRoot MTA (Dentsply Endodontics, Tulsa, 
OK, USA) to address esthetic concerns.12 After that time, two forms of MTA materials were categorized: 
the traditional gray MTA (GMTA) and WMTA. Scanning electron microscopy (SEM) and electron probe 
microanalysis characterized the differences between GMTA and WMTA and found that the major 
difference between GMTA and WMTA is in the concentrations of Al2O3, MgO, and FeO12,16 (Table 1). 
WMTA was found to have 54.9% less Al2O3, 56.5% less MgO, and 90.8% less FeO, which leads to the 
conclusion that the FeO reduction is most likely the cause for the color change.16 WMTA was also 
reported to possess an overall smaller particle size than GMTA22 while it was also suggested the 
reduction in magnesium could also contribute to the lighter color of WMTA.12 A reported elemental 
analysis comparing a commercial form of WMTA, a Portland cement, and the stated MTA patent can be 
observed in Table 2. 
Table 1. Chemical compositions of GMTA and WMTA (wt%) 
Chemical WMTA GMTA 
CaO 44.23 40.45 
SiO2 21.20 17.00 
Bi2O3 16.13 15.90 
Al2O3 1.92 4.26 
MgO 1.35 3.10 
SO3 0.53 0.51 
Cl 0.43 0.43 
FeO 0.40 4.39 
P2O5 0.21 0.18 
TiO2 0.11 0.06 
H2O + CO2 14.49 13.72 
Adapted from Asgary et al.16 
  
Table 2. Elemental analysis comparison portland cement and ProRoot WMTA (wt%) 
Element Portland cement WMTA Patent 
O 48.1 38.0 30.5 
Ca 40.3 37.1 37.2 
Si 6.7 6.5 7.9 
Al 2.1 0.6 1.7 
S 1.5 0.9 0.8 
K 0.9 0.0 0.3 
Mg 0.3 0.0 1.0 
Fe 1.0 0.0 2.8 
Bi 0 16.9 17.9 
Adapted from Dammaschke et al.12 
The setting mechanism of WMTA has been examined using X-ray photoelectron spectroscopy (XPS) that 
reported surface sulfur and potassium species increase 3-fold during the setting reaction. This suggested 
that MTA material setting time could be prolonged by the formation of a passivating trisulfate species 
layer, which may serve to prevent further hydration and reaction.12 This trisulfate species may serve a 
protective function, as it was reported that that WMTA flexural strength was significantly reduced when 
2-mm thick layers were exposed to sterile saline moisture for more than 24 h.23 Calcium release from 
MTA materials diminishes slightly with time22 while MTA materials were reported to form a porous 
matrix characterized by internal capillaries and water channels in which increased liquid/powder ratio 
produced more porosity and increased solubility.24 GMTA solubility levels have been reported to be 
stable over time, but the usually-reported pH of between 11 or 12 may slightly decrease.25 The high pH 
level of MTA materials has led some to theorize that the biologic activity is due to the formation of 
calcium hydroxide.22,23,24,25 WMTA solubility, hardness, and radiopacity has been compared to two 
Portland cements reporting that WMTA was significantly less soluble, exhibited greater Vickers 
hardness, and was more radiopaque.26 
There are some evidence that MTA materials possess a prolonged maturation process that continues 
past the stated setting time of 3–4 h, as GMTA retention strength for furcation repairs has been 
reported to resist significantly more dislodgement at 72 h as compared to 24 h.27 This was corroborated 
by one study that reported increase push-out strength up to 7 days28 with an additional study reporting 
maximum GMTA push-out strength observed at 21 days.27 Interestingly, GMTA that has not reached full 
maturity has been suggested to possess an ability to re-establish dislodgement resistance after partial 
displacement; but the re-established resistance strength decreased as dislodgement time increased 
after placement.27 
Different intracanal irrigant/oxidizing agents have been found to affect the push-out strength of GMTA 
as it was susceptible to sodium hypochlorite, sodium perborate mixed with saline, 30% hydrogen 
peroxide, sodium perborate mixed with 30% hydrogen peroxide, and saline at 7 days.29 GMTA push-out 
strength was also reported to be similar to Super-EBA and IRM when exposed to saline or sodium 
hypochlorite, but GMTA was more susceptible to oxidizing agents,29 which was reinforced by a report 
that a hydrogen peroxide-based canal preparatory agent significantly reduced the push-out strength of 
GMTA to dentin, whereas 2% chlorhexidine and 5.25% sodium hypochlorite did not.30 Another report 
found that perforation retention strength was not affected by preparing GMTA with either saline, sterile 
water, or lidocaine, but the bond strength to blood-contaminated root dentin was significantly less than 
that observed to uncontaminated dentin.28 Any adhesion that may be formed between GMTA and 
dentin may be stronger than the cohesive strength of the GMTA material, as it was reported that 
GMTA–dentin bond failures was usually cohesive within the MTA material.28 Furthermore, total GMTA–
dentin bond strength is also heightened by increased surface area, as one report states that 4 mm of 
GMTA has been reported to afford more resistance to displacement than 1-mm thick applications, and 
was not affected by previous calcium hydroxide placement.31 
Placement of GMTA using hand condensation techniques has been suggested to provide less porosity 
than ultrasonic-assisted techniques in simulated straight canals.32 However, different results were found 
that suggested a denser MTA fill was obtained in both straight and curved canals with a combination 
hand and ultrasonic placement over a solely manual condensation technique.33 GMTA root-end marginal 
adaptation and stability was reported to be significantly better than a ZOE preparation after being 
submitted to a computer controlled, simulated masticating apparatus that produced an estimated 5 
year equivalence of chewing cycles.34 Prefabricated posts luted with GMTA were reported to provide 
significantly less retentive strength than a glass-ionomer and zinc phosphate luting agents.35 WMTA has 
been reported to strengthen the cervical fracture resistance of immature sheep incisors as compared to 
the use of calcium hydroxide.36 Although this result is considered promising, it should be noted that 
within the groups sample number were low (<10) and the sample dimensions were also varied in 
dimension. 
WMTA and a ZOE preparation was found to have similar antibacterial properties against Staphylococcus 
aureus, Enterococcus faecalis, and Pseudomonas aeruginosa in a direct contact test37 while substituting 
0.12% chlorhexidine gluconate provided more antibacterial activity against Actinomyces odontolyticus, 
Fusobacterium nucleatum, Streptococcus sanguis, E. faecalis, Escherichia coli, S. aureus, P. aeruginosa, 
and Candida albicans than WMTA prepared with sterile water alone.38 This finding should be tempered 
with knowledge that MTA materials may not set when mixed with some chlorhexidine preparations.20 
Both freshly mixed and set GMTA was reported to be inhibitory to C. albicans using an antifungal tube-
dilution method39 while another study reported differences in that GMTA and WMTA at different 
powder/liquid mixtures were not equally effective at preventing the growth of C. albicans.40 Both WMTA 
and GMTA in concentrations of 50 and 25 mg/ml were equally inhibitive against C. albicans for up to 7 
days; however, at lower concentrations only GMTA was effective.40 This is evidence of not only the 
importance of proper powder/liquid ratios but also raises possible questions concerning that the two 
MTA preparations may not be equally effective in some clinical applications. 
In conclusion, MTA materials are derived from Portland cement, and although it could be inferred that 
Portland cement could serve as a suitable substitute, it is important to emphasize that MTA products 
and Portland cement are not identical materials. MTA materials have been reported to have a smaller 
mean particle size, contain less heavy metals, have a longer working time, and appears to have 
undergone additional processing/purification than the Portland cement parent compound. WMTA has 
been marketed since 2002 due to esthetic considerations and contains less iron, aluminum, and 
magnesium oxides than its GMTA counterpart. Both materials undergo a hydration setting reaction that 
is said to reach an initial set in 3–4 h but whose maturation and resistance to dislodgement increases 
with time. The physical properties and setting time of MTA materials can be affected by different 
preparation liquids and both WMTA and GMTA have been shown to possess antibacterial and antifungal 
activity, which is presumably due to its pH. 
3. Microleakage studies 
The success of an endodontic material may largely depend on its sealing ability, as most post-treatment 
endodontic disease is thought to occur due to tissue and other materials in uncleaned and/or 
unobturated areas of the root canal system that egress into the surrounding tissues.41 
3.1. In vitro dye/fluid filtration method leakage studies 
The microleakage of MTA materials compared to other traditional endodontic materials via in vitro dye 
and fluid filtration methods have been the subject of many studies.42,43,44,45,46,47,48,49,50,51,52,53,54,55,56, 
57,58,59,60,61,62,63,64 GMTA has been reported to have less microleakage than amalgam,42,43,44,45,47,48,51,52 zinc-
oxide-eugenol (ZOE) preparations,42,43,44 and a conventional glass-ionomer material59 when used as a 
root-end restoration following apical resection. However, other studies reported no difference in 
leakage between MTA materials and zinc-oxide-eugenol preparations,45,51,52,59 and conventional glass-
ionomer restorative materials.48 The minimal thickness for MTA to effectively seal the apical area has 
been investigated with one study reporting a placement thickness of at least 3 mm49 with another report 
stating a minimal of 4 mm is required for significant microleakage prevention.50 The addition of calcium 
chloride has been reported to enhance the sealing ability of both GMTA and WMTA, probably by the 
effect of calcium chloride's enhancement of MTA material setting time.57 WMTA and GMTA have been 
compared for the sealing of simulated canals with open apices using thicknesses of 2 and 5 mm followed 
by gutta percha obturation either immediately after MTA material placement or 24 h later.53 Results 
found that GMTA had less microleakage than WMTA in samples obturated 24 h after MTA placement; in 
all groups 5 mm of MTA material allowed less leakage. Based on the results, the authors recommended 
a 5-mm GMTA apical barrier placed for treatment of open apices with gutta percha obturation followed 
24 h later.53 Visual topography evaluations of root-end restorations restored with GMTA, ZOE materials, 
and amalgam have reported that root-end restoration finishing method had no effect on marginal 
adaptation of GMTA and ZOE material63 while another report stated that GMTA appeared to have better 
root-end marginal adaptation than amalgam.64 
For repair of furcation perforations, a ZOE preparation was reported to provide a better seal than GMTA 
at 24 h, after which no difference in leakage was observed.60 However, in another report, GMTA was 
found to allow more microleakage in furcation repairs when compared to a ZOE preparation and a self-
etch, one step bonding agent.58 The furcation perforation repair microleakage of GMTA and WMTA was 
compared from both an orthograde and retrograde direction.56 The results found no difference in 
leakage between the two MTA materials; but the more interesting findings were that significantly more 
leakage was found from a microleakage challenge from an orthograde direction.56 This suggests an 
impelling need for an adequate coronal barrier material over MTA furcation repairs to adequately 
protect against coronal microleakage. 
The microleakage of MTA materials used for root canal obturation has been reported by two studies.54,61 
The first study suggested that GMTA displayed more microleakage than laterally-condensed as well as 
thermoplasticized gutta percha54 but this was contrasted by the other study which reported that both 
WMTA and GMTA allowed less apical microleakage than warm, vertically condensed gutta percha.61 The 
second study also reported no significant difference in leakage between GMTA and WMTA, but 
importantly noted that root canal obturation with MTA materials would severely limit retreatment 
options and should be considered in only select cases.61 Another report reported that root resection of 
canals obturated with GMTA did not affect its sealing ability.62 
3.2. In vitro bacterial leakage studies 
The microleakage of MTA materials has also been evaluated, to a lesser extent, using bacterial 
penetration methods.31,41,65,66,67,68,69,70,71,72,73,74,75 GMTA has been evaluated for resistance against apical 
bacterial leakage when utilized as a root-end filling compared with amalgam and ZOE materials within 
endodontically prepared but unobturated root canals inoculated with Staphylococcus epidermis41 and 
Serratia marcescens.65 GMTA was found to have significantly more resistance to S. epidermis 
penetration than amalgam and ZOE preparations with no leakage evident after 90 days, with the other 
materials exhibiting bacterial penetration ranging from 6 to 57 days.41 The second study found that 
GMTA resisted S. macescens penetration for up to 49 days after inoculation while the amalgam and ZOE 
materials displayed trends for more bacterial penetration.65 WMTA and a bonded polymer-based 
material were found to exhibit similar root-end bacterial leakage resistance using a Streptococcus 
salivarius model with both materials having significantly less bacterial leakage than a ZOE preparation.71 
GMTA was also reported to allow significantly less E. coli endotoxin penetration using a modified 
Limulus Amebocyte Lysate test than amalgam and two ZOE preparations over a 12-week evaluation [69]. 
In contrast, GMTA was found to have the same bacterial penetration resistance as a ZOE preparation, 
amalgam, a bonded resin composite, as well as a bonded amalgam during a 12-week evaluation using 
Streptococcus salivarius.68 Similar results were reported during a 47-day study with GMTA compared 
against a polyacid-modified resin composite and a ZOE preparation using Prevotella nigrescens.70 
Furthermore, WMTA root-end fillings contaminated with either blood, saline, or saliva during placement 
were found to display varying resistance to Staphylococcus epidermidis with saliva contamination 
causing significantly more leakage.72 
When used as perforation repair materials, GMTA did not demonstrate any bacterial leakage during a 
45-day evaluation while approximately half of the amalgam-repaired furcations allowed penetration and 
transmission of F. nucleatum.68 Furthermore, no significant difference was found between GMTA and 
WMTA in the resistance to F. nucleatum penetration when used for furcation repair.67 When used in the 
treatment of immature apices, GMTA has been reported to provide resistance to bacterial penetration 
by E. faecalis and S. epidermis but not Enterobacter aerogenes.31 A similar report reinforced GMTA 
resistance to E. faecalis penetration with no leakage identified by E. faecalis 16S rDNA polymerase chain 
reaction assay after 10 days.73 GMTA was also evaluated against Actinomyces viscosus microleakage for 
up to 70 days in simulated immature apices that had received either a 2- or 5-mm apical GMTA 
restoration, or a series of 2-mm GMTA apical retrograde fillings. Results reported that only the 5-mm 
thick restoration resisted microleakage for the entire evaluation, and exhibited significantly less leakage 
compared to the positive control and other GMTA groups.74 When evaluated as a coronal barrier, no 
difference against human saliva bacterial penetration was found between GMTA, WMTA, or a resin-
modified glass-ionomer restorative material.75 One study attempted to evaluate the in vivo coronal 
sealing ability of WMTA in canine endodontically prepared and obturated root canals, but no conclusive 
results were found.76 
In conclusion, MTA materials have been investigated using dye, fluid filtration and bacterial infiltration 
leakage methods. The majority of the dye and fluid filtration studies suggest that MTA materials overall 
allow less microleakage than traditional materials when used as an apical restoration while providing 
equivalent protection as a ZOE preparation when used to repair furcation perforations. GMTA and 
WMTA were shown to provide equivocal results compared against gutta percha when used as a root 
canal obturation material in the limited number of microleakage studies. MTA materials have been 
suggested to afford less microleakage than traditional materials in a majority of bacteria-based 
microleakage studies when used as an apical restoration, furcation repair, and in the treatment of 
immature apices. In both fluid filtration and bacterial leakage models, 3 mm of MTA material is 
suggested as the minimal amount for protection against microleakage while 5 mm is suggested in the 
treatment of immature apices. 
3.3. Biocompatibility studies 
3.3.1. In vitro studies 
In vitro biocompatibility evaluations of MTA materials have been richly reported in the 
literature.77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103 The mutagenicity of GMTA, ZOE-
based, root-end filling materials, as well as positive and negative controls were evaluated using an Ames 
mutagenicity assay in which the materials were incubated with Salmonella Typhimurium LT-2 strains 
with reverting bacteria colony counts measured.77 None of the root-end filling materials, including 
GMTA, produced statistically significant higher Ames test reversion rates, which indicates that none of 
the root-end filling materials would be considered mutagens.77 Other evaluations have reported no 
genotoxic effects of WMTA or Portland cements by single cell gel (comet) assay on peripheral human 
lymphocytes,78 mouse lymphoma cells,79 as well as Chinese hamster ovary cells.80 Taken as a whole, 
none of the studies have shown genotoxic effects of MTA. Although specific carcinogenicity testing for 
MTA materials was not found in the literature, it is thought that all carcinogens are mutagens. 
Therefore, based on the existing literature, it is unlikely that MTA is a carcinogenic substance since it is 
not a mutagenic substance. 
The cytotoxicity of GMTA, amalgam, ZOE, as well as positive and negative controls was measured using a 
cell viability assay for mitochondrial dehydrogenase activity in human periodontal ligament fibroblasts 
after 24-h exposure to extracts of varying concentrations of the test materials, in both freshly mixed and 
24-h set states.82 In the freshly mixed state, the sequence of toxicity was amalgam > Super-EBA > MTA. 
In the 24-h set state, the sequence of toxicity at a low extract concentration was Super-EBA > MTA, 
amalgam; while at higher extract concentrations was Super-EBA > amalgam > MTA.82 Similarly, another 
report reinforced that GMTA did not negatively affect human periodontal ligament fibroblast 
mitochondrial dehydrogenase activity.86 SEM analysis of periodontal ligament fibroblasts was found to 
have a normal morphology and exhibit growth and attachment to 24-h set MTA surfaces.83 However, in 
the freshly mixed GMTA samples, the cells were round, less in density, exhibited surface defects, and 
lacked attachment to MTA.83 If the quality and quantity of cell attachment to the root-end filling 
materials can be used as a criterion to evaluate material's toxicity, then set GMTA appears to be less 
cytotoxic than fresh GMTA.83 In a comparable study involving resected root surfaces, PDL cell 
attachment was observed on GMTA but was absent on gutta percha.87 Similarly, PDL fibroblasts have 
been reported to display enhanced proliferation on WMTA in a study that analyzed cellular metabolic 
activity.88 These analyses indicated that WMTA induced a general osteogenic phenotype in PDL 
fibroblasts, with induction of alkaline phosphatase activity, as well as production of osteonidogen, 
osteonectin, and osteopontin.88 
The cytotoxicity of amalgam, ZOE preparations, and GMTA was reported via an ATC L-929 mouse 
fibroblast agar overlay and radiochromium method.81 Results of the agar overlay found that set 
amalgam was significantly less toxic compared to the other materials, while the set GMTA was 
significantly less toxic than the ZOE preparations. Contrasting, the radiochromium method suggested 
that GMTA was significantly less toxic than amalgam. Although it was suggested that the increased agar 
cytotoxicity of the ZOE preparations was due to the leaching of eugenol, the report concluded that 
GMTA was no more cytotoxic than other root-end filling materials currently in use.81 These findings 
were reinforced by another study using human gingival fibroblasts and a L-929 cell line.85 GMTA and a 
CP titanium alloy was found to have similar affect on gingival fibroblast cellular activity, causing no 
negative affect on cell viability, Prostaglandin E2 assays, protein and lactate synthesis, and cell 
proliferation. Overall results indicated that gingival fibroblast growth was similar for both GMTA and 
titanium, as either material did not initiate PGE2 release or cause alteration of gingival fibroblast cellular 
metabolism.84 
The high pH value of freshly mixed GMTA was found to induce cell lysis in L-929 mouse fibroblasts and 
macrophage cell lines in direct contact with the material; however, set GMTA demonstrated favorable 
biocompatibility with no observed effect on cell morphology as well as limited impact on cell growth at 
72 h.89 WMTA, as well as calcium hydroxide and a ZOE sealer, was shown not to affect the cell viability 
or the Prostaglandin E2 synthesis of murine macrophages and fibroblasts.91 In a different study, murine 
fibroblast and macrophage cells displayed significantly greater cytotoxicity using flow cytometry with 
WMTA prepared with 0.12% chlorhexidine gluconate than to WMTA prepared with sterile water.90 
MG-63 cultured human osteoblasts were exposed to GMTA with cellular response evaluated via alkaline 
phosphatase activity as well as inflammatory cytokine and osteocalcin production.92 The MG-63 cells 
were found to adhere closely to the GMTA surface while cytokines for osteoclast recruitment (M-CSF) 
and activation (IL-1α, IL-1β, IL-6) were found to be produced, along with observed osteocalcin 
production and alkaline phosphatase activity.92 This led to speculation that GMTA causes osteoblast 
adhesion with release of cytokines from the attached osteoblasts resulting in osteoclast activation via 
coupled resorption. Therefore, MTA might be considered a suitable substitute for PMMA when used for 
an orthopedic bone cement.92 This was corroborated by another study that found that MG-63 
osteoblast-like and Saos-2 human osteosarcoma cells exposed to GMTA exhibited viability, attachment, 
proliferation, and collagen production after 24 h.96 
ELISA assays have been used to assess the osteocompatibility of GMTA by monitoring the expression of 
Interleukin (IL)-1α, IL-6, IL-8, IL-11 and macrophage colony stimulating factor (M-CSF).93 Although 
osteoblast cell growth was reported, production of IL-1α and IL-11 were not detected from the cells 
exposed to the GMTA materials. However, osteoblastic IL-6 and IL-8 were detected as well as M-CSF.93 
Osteoblasts in another study were found to demonstrate good adhesion and spreading on GMTA 
surface, but did not demonstrate the same ultrastructural characteristics when exposed to a ZOE 
preparation and amalgam.94 GMTA osteocompatibility was reported after U2OS human osteosarcoma 
cell lines were incubated with GMTA and evaluated using Western blot assay.95 In this study, GMTA had 
a positive effect on the mitogen-activated protein kinase (MAPK) pathways. The authors also reported 
that a dose-dependent influence was present on the extracellular signal-regulated kinase MAPK 
pathway, which is a known pathway leading to osteoblastic activation and overgrowth.95 This was 
reinforced by another study that reported both 1- and 28-day cured GMTA and WMTA displayed 
biocompatibility when exposed to a Saos-2 human osteosarcoma cell line,97 while an additional another 
study reported both cell attachment and IL-4 and IL-10 cytokine production.98 
Freshly mixed or set GMTA has been reported to display little to no neurotoxicity. Neurotoxicity effects 
were quantitatively assessed by exposing fetal mice cortical neuronal and glial cells and measuring 
lactate dehydrogenase activity, an assay for cell death.99 In this study, an amalgam, ZOE preparation, 
and a resin endodontic sealer exhibited neurotoxicity that affected approximately 50–100% of the 
neuronal and glial cells, while GMTA exhibited little to no neurotoxicity.99 GMTA has also been reported 
to be biocompatible with a murine cementoblast model, with the cementoblasts displaying 
ultrastructural attachment to GMTA surface with normal reverse transcriptase polymerase chain 
reaction analysis (RT-PCR) indicating osteocalcin production.100 Another study suggested that WMTA 
was more biocompatible than GMTA in supporting human cementoblast and keratinocyte growth.103 
WMTA effect on dental pulp cell viability and proliferation has been evaluated using mouse MDPC-23 
odontoblast-like cells and OD-21 undifferentiated pulp cells. After 24-h exposure to WMTA, apoptosis 
was not induced in either cell line, and WMTA was reported to cause DNA synthesis increase, suggesting 
a positive effect on cellular proliferation.101 This was reinforced by another report that suggested that 
WMTA had more of a stimulating effect on human dental pulp cells than a commercial calcium 
hydroxide preparation.102 
3.3.2. In vivo studies 
GMTA was reported to induce little or no inflammation compared to a ZOE preparation when implanted 
into guinea pig mandibles, with one GMTA sample demonstrating bone formation on its surface.104 
Similar tissue reactions with both GMTA and Portland cement that demonstrate direct bone deposition 
on the materials’ surfaces have been reported.105 Another study found no inflammation difference in rat 
connective tissue exposed to both WMTA and a Portland cement mixture.106 An additional study 
reported a more favorable tissue reaction to GMTA compared to amalgam and two ZOE preparations 
that were implanted in guinea pig tibias and mandibles with direct bone apposition observed on some 
GMTA samples.107 However, a different study found no difference in rat bone tissue reaction between 
WMTA, GMTA, amalgam, and an epoxy-based, calcium hydroxide root canal sealer.108 In a rat connective 
tissue model, GMTA was observed to induce calcification which served as a nidus for ossification,109 
whereas in a similar model amalgam, WMTA, and GMTA were reported to have similar Cox 
inflammatory cell grading at 3 weeks, although the amalgam samples exhibited more severe 
inflammation at the study onset than the MTA samples.110 GMTA and a calcium hydroxide-containing 
root canal sealer was reported to be well tolerated when implanted into rabbit ear chamber connective 
tissue, although the root canal sealer induced connective tissue dissolution with precipitate barrier 
formation.111 
When used as a root-end restoration in a canine model, GMTA was reported to be associated with 
significantly less periapical inflammation than amalgam at both 5 and 18 weeks after placement, with 
almost all of the GMTA specimens exhibited new cementum tissue growth on the GMTA surface.112 In 
another study, GMTA and an epoxy-based, root canal cement both exhibited excellent canine peri-
radicular tissue response at 60 days with no statistically significant difference between the materials for 
new cementum, bone, or periodontal ligament formation.113 These results were corroborated by a 
report that evaluated the canine peri-radicular response to GMTA and a ZOE preparation which found 
the presence of periodontal ligament formation and hard tissue ingrowth on the GMTA surface.114 
For periapical surgery on obturated canals associated with induced periapical lesions in a canine model, 
GMTA was reported to induce a favorable periapical tissue healing response compared to amalgam and 
a ZOE preparation.115 Blinded histologic evaluation 42 days after periapical surgery reported that tissues 
adjacent to GMTA displayed a minor degree of inflammation, while tissues adjacent to the ZOE 
preparation moderate inflammation. Tissues adjacent to amalgam exhibited marked inflammation. Only 
the GMTA groups exhibited cementum growth over the root-end filling material which led to 
speculation that the new cementum may have originated from both the periodontal ligament and 
alveolar bone.115 Using a canine model, neither freshly prepared nor fully-set GMTA was found to make 
a difference in periapical healing, with new cementum deposition and bone healing observed in both 
groups.116 A subsequent study evaluated the healing of canine periapical tissues after calcium sulfate 
and GMTA placement following peri-radicular surgery. Histologic analysis 4 months post-surgery 
revealed that simultaneous use of calcium sulfate and GMTA does not significantly affect peri-radicular 
healing.117 
Periapical tissue response to GMTA and zinc-free amalgam root-end filling materials using a mammalian 
Cynomolgus monkey model found that at 5 months after surgery, peri-radicular tissues adjacent to the 
amalgam restorations displayed moderate to severe inflammation with fibrous capsule formation, while 
only one tissue specimen adjacent to the GMTA material displayed inflammation.118 For both groups, 
cementum was observed to have re-formed associated with the resected root surface, but no 
cementum was observed on the amalgam surface. However, cementoblast activity associated with thick 
cementum was observed on the GMTA surface with five of six specimens, with some specimens 
exhibiting new periodontal fiber insertion.118 
For furcation repair, GMTA and amalgam were compared using a canine model using both an 
immediate- and delayed-repair scenario.119 Endodontically treated teeth with standardized furcation 
perforations were repaired with both materials either immediately or after 6 weeks of salivary 
contamination. For the immediate-repair situation at 4 months, the amalgam samples were all 
associated with inflammation and no repair site cementum formation. The GMTA-repaired specimens 
were characterized by lack of inflammation with cementum formation noted in five of six specimens. For 
the delayed-repair group, half of the GMTA-repaired specimens were free from inflammation with 
cementum formation. The delayed-repair group with amalgam-restored specimens exhibited either 
moderate or severe inflammation. Although this study did not use statistical analysis, the authors 
concluded that GMTA had potential when used for furcation repairs.119 
GMTA was compared to a resin-based, calcium hydroxide root canal sealer repairing lateral root 
perforations at the junction of the middle and coronal thirds using a canine model.120 At 30 days, GMTA-
treated samples displayed either cementum deposition and/or small areas of ankylosis adjacent to the 
perforation site. Furthermore, all areas were reported to exhibit little inflammation except for areas 
with GMTA overfill. However, the root canal sealer largely induced chronic inflammation and ankylosis, 
with localized periodontal ligament necrosis associated with overfilled areas.120 At 180 days, GMTA-
repaired specimens exhibited no ankylosis with most specimens exhibiting healing characterized by 
cellular cementum formation with PDL formation between the cementum and alveolar bone. In 
contrast, sealer-repaired specimens exhibited some cementum formation but was associated with a 
chronic inflammatory response consisting of foreign body giant cells and macrophages. Although the 
authors reported that this study supported the use of GMTA for perforation repair, there was no 
statistical analysis of the data.120 The histologic response of canine periapical tissues was reported 
comparing GMTA and a glass-ionomer material used as obturation materials. Six months after 
obturation, all root canals obturated with GMTA exhibited apical closure with new cementum 
formation, whereas only partial cementum closure was observed in a minority of the glass-ionomer 
materials. Although both materials were reported to exhibit good biocompatibility, the authors 
suggested that GMTA exhibited better biologic properties.121 
In conclusion, regarding the biocompatibility of MTA materials, studies in general tend to support the 
biocompatibility of both GMTA and WMTA, although cytotoxicity studies are inclined to suggest less 
response to the set material as compared to the freshly prepared material. Nevertheless, the published 
literature tends to support the biocompatibility of both the set material and freshly prepared material, 
especially in relation to other dental materials. 
3.4. Characterization of MTA biocompatibility 
Numerous studies have been devoted to evaluate the biocompatibility of GMTA and WMTA. 
Interestingly, only a few studies have attempted to identify the specific quality of MTA materials that 
provides their biocompatible nature. Some reports speculated that MTA material biocompatibility was 
derived from calcium hydroxide formation,11,22,24,90,120 and one report did observe the formation of a 
white interfacial material between GMTA and tooth structure when exposed to a phosphate-buffered 
physiologic solution.48 
Sarkar et al.10 reported the first investigation aimed solely at investigating the biocompatible nature of 
MTA materials and reported the formation of white precipitates within 1–2 h on the GMTA surface 
along with suspended precipitates within the physiologic phosphate-buffered saline solution. SEM 
analysis of these precipitates revealed a globular morphology with chemical composition of oxygen, 
calcium, and phosphorus, along with trace amounts of bismuth, silicon, and aluminum, while X-ray 
diffraction (XRD) analysis suggested the presence of hydroxyapatite, although it should be noted that 
the calcium-to-phosphorus ratios reported differed from that reported of hydroxyapatite.10 In spite of 
this disparity, this report was reinforced by Bozeman et al.122 who also used XRD and SEM analysis of 
both WMTA and GMTA crystal precipitates under the same conditions. This report reinforced that the 
crystal precipitates on both MTA materials were chemically and structurally similar to hydroxyapatite. 
Interestingly, GMTA was found to produce twice as much hydroxyapatite crystals as WMTA, which leads 
to some speculation that GMTA and WMTA may not possess the same level of bioactivity.122 
4. Clinical applications of mineral trioxide aggregate materials 
4.1. Pulp-capping 
4.1.1. Animal models 
GMTA has been compared with calcium hydroxide as a pulp-capping medicament using a cynomolgus 
monkey model in which GMTA was found associated with little tissue inflammation and a thick and 
continuous dentin bridge at 5 months. In contrast, only one-third of the calcium hydroxide-treated 
specimens exhibited dentin bridge formation with all displaying severe tissue inflammation.123 A canine 
model study reported similar results with GMTA exhibiting good tissue response and dentinal bridge 
formation while one-third of the calcium hydroxide specimens exhibited dentin bridge formation with 
75% of the specimens displaying bacteria and chronic pulp tissue inflammation.124 Another canine model 
study reported that GMTA when used as a pulp-capping medicament induced an osteodentin matrix at 3 
weeks that was typically observed with reparative dentin,125 while WMTA in a different study was 
reported to exhibit neodentinal bridge formation at 2 weeks with an ultrastructural intimate 
relationship observed between the pulpal tissues and the WMTA crystals.126 WMTA and GMTA used as 
pulp-capping agents were both reported to form calcified bridge formation in which all WMTA and a 
majority of the GMTA specimens exhibited complete calcified bridge formation with mild inflammatory 
reactions at 2 weeks.127 In a rodent pulp-capping model, GMTA was reported to induce complete hard 
tissue bridge formation at 2 weeks that stained positive for dentin sialoprotein.128 
GMTA was reported to foster the same tissue reaction as two sterilized Portland cement preparations 
when used as a pulpotomy medicament in a canine model, with all four materials associated with a 
dentin bridge with normal pulpal tissue at 120 days.129 WMTA was reported to produce both incomplete 
and complete barrier formation with mild tissue inflammation when used as an apexification 
medicament in a canine model. Specimens that were treated solely with WMTA were found to produce 
barriers within the root confines whereas specimens treated first with calcium hydroxide had mostly 
incomplete barrier formation that were predominately extracanal, beyond the previous apical area.130 
4.2. Human studies 
4.2.1. Pulp-capping 
A prospective study compared calcium hydroxide and GMTA as permanent dentition pulp-capping 
medicaments using third molars with mature apices in a split-mouth design.131 Mechanical pulp 
exposures in 11 pairs of maxillary third molars were analyzed at 1 week, and at 2, 3, 4, and 6 months 
after treatment. The calcium hydroxide specimens were hallmarked by tissue inflammation with a 0.15-
mm thick dentinal bridge with adjacent pulp tissue necrosis noted at 6 months. These findings were 
contrasted with GMTA specimens displaying mild tissue reactions with a 0.28-mm dentin bridge noted 
at 2 months, with 6-month specimens displaying 0.43-mm dentin bridge formation, no pulp tissue 
inflammation, all associated with a near-regular odontoblastic layer.131 However, the authors did 
acknowledge a small sample size and the need for further studies. A second prospective study compared 
WMTA and a calcium hydroxide preparation as direct pulp cap medicaments in 48 third molars in a 
single-blinded, randomized, controlled clinical study.132 At 30-days post-treatment, the WMTA group 
had 20 teeth with clinically normal pulpal status while three were diagnosed with reversible pulpal 
disease. The calcium hydroxide group had 17 teeth with normal pulpal signs, 6 exhibited signs of 
reversible pulpal disease, and 1 was diagnosed with irreversible pulpal disease. At the 136-day recall, all 
23 teeth present for the WMTA group were clinically diagnosed as successful as well as 22 teeth of the 
calcium hydroxide group. At both evaluation periods, no significant difference was found between the 
groups in regards to the clinical presentation as well as the histologic status.132 Two case studies 
involving GMTA used as a deciduous pulp-capping agent and in treatment of dens evaginatus reported 
good follow-up results with minimal clinical or radiographic pathology.133,134 
For use of MTA materials as direct pulp cap medicaments, the two clinical prospective studies suggest 
that both GMTA and WMTA may perform equally as well as traditional calcium hydroxide in non-carious 
mechanical pulp exposures in teeth with normal pulp tissue. Although the initial results are positive, 
further clinical studies are needed, especially in the more clinically relevant situations involving carious 
pulp exposures before MTA materials can be unequivocally indicated for a direct pulp-capping agents. 
4.2.2. Pulpotomy dressing 
There are seven prospective studies involving the use of MTA materials as pulpotomy dressings for 
primary teeth135,136,137,138,139,140,141 while two studies investigated a similar role in permanent teeth.142,143 
GMTA and formocresol were compared as pulpotomy dressings in primary molars with carious pulp 
exposures, with only one reported failure (internal resorption in a formocresol-treated specimen) in the 
32 teeth available for evaluation ranging 6–30 months.135 Pulp canal obliteration was noted at a higher 
frequency in GMTA-treated specimens (7/17) than that seen with formocresol (2/15).135 Another study 
compared GMTA, WMTA, and formocresol as pulpotomy dressings in primary teeth demonstrating 
radiographic caries pulpal involvement with recalls at 1, 3, 6, and 12 months.136 All teeth were judged as 
clinical and radiographic successes at 1 month, while at 3 months one WMTA-treated tooth failed due to 
abscess formation; all remaining teeth were rated successful at 6 months. At 12 months all GMTA 
specimens were judged to be successful, but three WMTA-treated teeth were found to be clinical and 
radiographic failures, along with two formocresol-treated teeth. GMTA as found to provide a 
significantly better outcome than WMTA, with no difference found between WMTA and formocresol.136 
These results were contrasted by a different randomized, prospective study that compared formocresol 
and WMTA as pulpotomy medicaments in primary molars. At 24 months none of the WMTA-treated 
teeth exhibited clinical or radiographic pathology while the formocresol-treated teeth demonstrated 
approximately 13% radiographic and 2% clinical failure.139 Another longer (range 4–74, mean 38 months) 
prospective, randomized study found both formocresol and a MTA material (authors did not delineate 
MTA material type) equally successful statistically when used as pulpotomy dressings in primary molars 
with carious pulp exposures.140 Similar results were reported in a 12-month study in which WMTA was 
compared with calcium hydroxide for pulpotomy treatment in 90 cariously exposed primary molars.141 
In this study, treatment was curiously provided in two sessions, in which WMTA and/or the calcium 
hydroxide paste was applied after an interim dressing of a corticosteroid/antibiotic solution. At the end 
of the evaluation period six failures had occurred with the calcium hydroxide treatments and two 
failures had occurred with the WMTA treatments.141 
GMTA and WMTA were evaluated as pulpotomy dressings for primary molars in two different short-
term studies137,138 by the same group of researchers. The first reported that GMTA exhibited clinical 
success at 6 months with radiographic dentin bridges observed in 50% of the specimens.137 The second 
study found similar results with WMTA but radiographic analysis was limited only to the mandibular 
teeth. Within this limitation, results were that 69% of the pulp canals demonstrated signs of stenosis, 
11.5% of the pulp canals exhibited dentin bridges, and one canal exhibited possible early signs of 
internal resorption adjacent to the WMTA dressing.138 In these two studies no statistical difference was 
found in the rate of pulp canal stenosis between GMTA and WMTA whereas GMTA was found to 
produce significantly more dentin bridges.137,138 
One prospective clinical study reported GMTA as a pulpotomy medicament in 31 vital, cariously 
exposed, first molar permanent teeth.142 At 24 months, 79% of the 28 teeth available for evaluation 
maintained a positive response to vitality testing with the remainder free of clinical or radiographic 
pathology. Sixty-four percent of the specimens had pulpal radiographic hard tissue bridge formation, 
while seven teeth that initially presented with immature apices displayed radiographic signs of 
continued root development.142 Although this study is favorable, it should be noted that the teeth were 
restored immediately with the manufacturer recommendation of interim placement of the MTA 
dressing with a moist cotton pellet not observed. However, this did not appear to affect the results and 
could identify the importance of an early coronal seal provided by a definitive restoration, especially in 
the pediatric population. Furthermore, it would have been of interest if this study had been able to 
compare other treatment groups using traditional pulpotomy dressing materials. It is hoped that the 
authors will report the continued follow-up results of this work. 
The histologic pulpal response comparing WMTA to calcium hydroxide as pulpotomy dressings was 
investigated in premolar teeth extracted for orthodontic purposes, reporting that WMTA induced a 
more homogenous and continuous dentin bridge with less pulpal inflammation than calcium hydroxide 
at both 4 and 8 weeks after treatment.126 A favorable outcome was also reported in a private 
endodontic practice assessment using WMTA as a pulpotomy dressing in 23 permanent teeth that 
exhibited clinical signs of irreversible pulpal disease.143 Of the 19 teeth available for recall (range 6–53 
months) one tooth presented signs of persistent pulpal disease; this case did not receive a permanent 
restoration and presented with recurrent caries upon recall. Based on these limited results, the authors 
reported a Kaplan–Meier survival probability of 0.95.143 
4.2.3. Other MTA material use 
Compared to other clinical usage of MTA materials, very few clinical studies exist that report the 
outcome of clinical use of MTA materials as root-end filling materials and root repair, as in the clinical 
cases noted in Fig. 2, Fig. 3. A prospective 24-month clinical study compared GMTA to a ZOE preparation 
as root-end filling materials in 122 adult patients referred for endodontic surgery.144 At both 12- and 24-
month recalls, acceptable results were noted with both materials; while the authors implied a higher 
success rate with GMTA treatment, no statistical difference was noted between the two materials.144 It 
is hoped that this 24-month report will continue to be followed. A retrospective study concerning GMTA 
use for root perforation repair in 16 cases within an endodontic residency caseload has been 
reported.145 This report involved five lateral root perforations, five strip perforations, three furcation 
perforations, and three apical perforations that were treated with a follow-up range of 12–45 months. 
Results were that all treatments demonstrated clinical and radiographic signs of healing with return of 
normal radiographic architecture to the repair sites.145 Although these initial results are promising, this 
study represents a limited number of clinical cases and no comparison group was included. Clinical case 
reports in which GMTA has been used to repair horizontal root fractures, root resorption, internal 
resorption, and furcation perforations with both clinical and radiographic success have also been 
reported.146,147,148,149,150,151,152 
 Fig. 2. (A) Preoperative radiograph of maxillary central incisor. (B) Reveals apical surgical procedure 
accomplished with WMTA apical restoration placed. (C) Post-operative radiograph. Images courtesy of Dr. 
Brian Min. 
 Fig. 3. (A) Preoperative radiograph of mandibular second molar with furcal perforation. (B) Shows WMTA 
placement. (C) Post-operative radiograph. Images courtesy of Dr. Brian Min. 
At the time of this review, no prospective studies using MTA materials for apexification and/or 
apexogenesis procedures have been reported. However, successful individual case reports of using 
GMTA and/or WMTA for apexification/apexogenesis treatments do exist.147,148,153,154,155,156 
5. Conclusion 
The physical properties, sealing ability, biocompatibility, and clinical performance of MTA materials have 
been discussed. MTA materials appear not only to demonstrate acceptable biocompatible behavior but 
also exhibits acceptable in vivo biologic performance when used for root-end fillings, perforation repairs, 
pulp-capping and pulpotomy, and apexification treatment. However, it should be noted that the 
supporting data have been overwhelmingly from either in vitro or animal studies. Reports have strongly 
suggested that the favorable biologic performance exhibited by MTA materials is due to hydroxyapatite 
formation when these materials are exposed to physiologic solutions. Although some studies suggest 
that the less-expensive Portland cement parent compound could possibly be used in the place of MTA, 
characterization studies have shown that MTA materials are compositionally different than Portland 
cement and it is not recommended at this time that Portland cement can serve as a suitable MTA 
substitute. GMTA has been investigated more than the more-esthetic WMTA, and while some reports 
suggest that GMTA may invoke a more desirable biologic response than WMTA, existing reports as a 
whole are equivocal and more studies are encouraged. Although the overall results in human studies 
involving MTA materials are very positive, further longitudinal studies are encouraged, as at present 
insufficient well-designed and controlled clinical studies exists that allow systematic and meta-analysis 
review of MTA materials in all of its suggested clinical indications. 
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